(Q41060580)

26 September 2017

1 reference

title

The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease (English)

1 reference

26 September 2017

0 references

0 references

0 references

0 references

Meier-Ruge W

1

1 reference

PubMed ID

8736675

26 September 2017

Bertoni-Freddari C

series ordinal

2

1 reference

26 September 2017

1 January 1996

1 reference

Reviews in the Neurosciences

26 September 2017

1 reference

26 September 2017

7

1 reference

26 September 2017

1

1 reference

26 September 2017

1-19

1 reference

Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex.

26 September 2017

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Interregional correlations of resting cerebral glucose metabolism in old and young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

beta-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Energy, oxidative damage, and Alzheimer's disease: clues to the underlying puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Neurobiology of the aging brain: morphological alterations at synaptic regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Treatment of Alzheimer's disease. Molecular pathology versus neurotransmitter-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Age-dependent impairment of mitochondrial function in primate brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Future research in Alzheimer's disease using imaging techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Alzheimer patients and Down patients: abnormal presynaptic terminals are related to cerebral preamyloid deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Evidence for lysosomal processing of amyloid beta-protein precursor in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Glucose and memory in mild senile dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Effects of choline and glucose on atropine-induced alterations of acetylcholine synthesis and content in the caudate nuclei of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

21 January 2018

ATP and brain function

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Potentially Amyloidogenic, Carboxyl-Terminal Derivatives of the Amyloid Protein Precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Normal Processing of the Alzheimer's Disease Amyloid β Protein Precursor Generates Potentially Amyloidogenic Carboxyl‐Terminal Derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

ATP mediates fast synaptic transmission in mammalian neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Is cell aging caused by respiration-dependent injury to the mitochondrial genome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Coronal reconstruction images of glucose metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Molecular Genetics of Familial Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The genetic defect causing familial Alzheimer's disease maps on chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Protein folding in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Blood-brain barrier in toxic encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Excitatory amino acids and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

PRESENILE DEMENTIA ASSOCIATED WITH MOSAIC TRISOMY 21 IN A PATIENT WITH A DOWN SYNDROME CHILD

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Role of free radicals in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The role of neuronal energy in the neurotoxicity of excitatory amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Insulin increases glucose transfer across the blood-brain barrier in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Age as risk factor for sporadic dementia of the Alzheimer type?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Proteolytic cleavage of the Alzheimer's disease amyloid A4 precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Dementia in elderly patients: can the 3R mental stimulation programme improve mental status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Alzheimer's disease: a cell biological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Pathological correlates of dementia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Anterograde and retrograde enhancement of 24-h memory by glucose in elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Effects of prolonged co-dergocrine mesylate (Hydergine) treatment on local cerebral glucose uptake in aged Fischer 344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Senile dementia: a threshold phenomenon of normal aging? A contribution to the functional reserve hypothesis of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

What is primary and what secondary for amyloid deposition in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Neurochemical enzyme changes in Alzheimer's and Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Morphometric investigation of nerve cells, neuropil and senile plaques in senile dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Memory improvement by glucose, fructose, and two glucose analogs: a possible effect on peripheral glucose transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

An integrated theory of aging as the result of mitochondrial-DNA mutation in differentiated cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

A two-step hypothesis on the mechanisms of in vitro cell aging: cell differentiation followed by intrinsic mitochondrial mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Effects of co-dergocrine mesylate (Hydergine) in multi-infarct dementia as evaluated by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Mitochondrial DNA mutation associated with aging and degenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Alzheimer's disease: therapeutic strategies for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Dominantly inherited Alzheimer's disease: cerebral glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The role of amyloid beta-protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

The occult aftermath of boxing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Biologically active domain of the secreted form of the amyloid beta/A4 protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Is amyloid causally involved in pathophysiology of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Presynaptic cholinergic dysfunction in patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Metabolic processes in Alzheimer's disease: adenine nucleotide content and production of 14CO2 from [U-14C]glucose in vitro in human neocortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Mitochondrial function in brain tissue in primary degenerative dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Beta-amyloid precursor protein cleavage by a membrane-bound protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Brain aging and Alzheimer's disease, “Wear and tear” versus “Use it or lose it”

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Regional cerebral glucose metabolism is normal in young adults with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid ?-protein and tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Observations on the brains of demented old people

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Potentially amyloidogenic fragment of 50 kDa and intracellular processing of amyloid precursor protein in cells cultured under leupeptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Regulation of acetylcholine synthesis in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Mitochondrial genetics: a paradigm for aging and degenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Co-dergocrine, cerebral glucose utilization and maze performance in middle-aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Ultrastructural analysis of beta-amyloid-induced apoptosis in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Beta-amyloid protein promotes neuritic branching in hippocampal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

How ATP drives proteins across membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Lack of long-term effects after beta-amyloid protein injections in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Abnormal processing of multiple proteins in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1996.7.1.1

10.1515/REVNEURO.1996.7.1.1

21 January 2018

Identifiers

DOI

1 reference

release_5na7omtorfgf3ahmq53ls4wxyq

26 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5na7omtorfgf3ahmq53ls4wxyq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

8736675

1 reference

PubMed ID

8736675